julianlindsay_ (@julianlindsay_) 's Twitter Profile
julianlindsay_

@julianlindsay_

Research Pharmacist at @fredhutch @NCICancer and keen ocean swimmer.

ID: 1191587173281099777

calendar_today05-11-2019 05:25:22

31 Tweet

111 Followers

128 Following

NCIC (@ncicancer) 's Twitter Profile Photo

Dāˆ’/R+ URD highest risk for #CMV infection and mortality in alloHCT and potential candidates for targeted prophylaxis. Viral load 250 IU/mL ideal threshold to initiate pre‐emptive therapy in this population #TxID dx.doi.org/10.1111/tid.13… julianlindsay_

julianlindsay_ (@julianlindsay_) 's Twitter Profile Photo

Minutes away from presenting our single centre #CMV study along with Prof Morrissey A/Prof Sasadeusz and Michelle Yong at ICHS for an overview of CMV burden in AUS #ICHS2021 #TxID NCIC

Abby Douglas (@abbypdouglas) 's Twitter Profile Photo

Great first day of ICHS! CMV, transplant tourism, donor derived infections, invasive fungal infections, MDR pathogens, covid19- all in the mix! And with such a line up of experts! So privileged to hear from the best. Can’t wait for day 2. #ICHS2021

Great first day of <a href="/ICHS2021/">ICHS</a>!  CMV, transplant tourism, donor derived infections, invasive fungal infections, MDR pathogens, covid19- all in the mix! And with such a line up of experts! So privileged to hear from the best. Can’t wait for day 2. #ICHS2021
NCIC (@ncicancer) 's Twitter Profile Photo

Highly recommend watching this one back! Great resource for a very comprehensive review of infectious complications with MAb therapy Vicki Morrison "Spectrum and prophylaxis of infectious complications associated with monoclonal and bi-specific antibody therapy" Day 2.#ICHS2021

Francisco Marty, MD (@franciscomarty_) 's Twitter Profile Photo

Here is the handout of today's presentation on Controlling #Cytomegalovirus in #transplantation as part of #Melbourne #ICHS2021 session on tough #viruses and new treatments. Lots of new #CMV data below the #Covid19 radar! #TxID #IDtwitter link: dropbox.com/s/lnyf76bu8roq…

Here is the handout of today's presentation on Controlling #Cytomegalovirus in #transplantation as part of #Melbourne #ICHS2021 session on tough #viruses and new treatments. Lots of new #CMV data below the #Covid19 radar!

#TxID #IDtwitter

link: dropbox.com/s/lnyf76bu8roq…
NCIC (@ncicancer) 's Twitter Profile Photo

Please join us this Wednesday for our monthly JC. Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allo HCT julianlindsay_ & Impact of Preemptive Therapy for CMV on Toxicities after AlloHCT Dr SuAnn Ho unimelb.zoom.us/webinar/regist…

julianlindsay_ (@julianlindsay_) 's Twitter Profile Photo

Huge thanks to the ABMTRR and my excellent supervisors and collaborators monica slavin @PergamIC Dr’s Liu, Kong, Chen, Greenwood and others for helping put this together. An important report for Australian HCT centres. sciencedirect.com/science/articl…

BOPA Committee (@bopacommittee) 's Twitter Profile Photo

The session is on CMV management in allogeneic hematopoietic cell transplantation and our speaker will be julianlindsay_ from Sydney, Australia with @NickDun28458375 chairing the event For more details and to sign up, see link below: bopa.org.uk/event/my-resea…

The session is on CMV management in allogeneic hematopoietic cell transplantation and our speaker will be <a href="/JulianLindsay_/">julianlindsay_</a> from Sydney, Australia with @NickDun28458375 chairing the event

For more details and to sign up, see link below:

bopa.org.uk/event/my-resea…
BOPA Committee (@bopacommittee) 's Twitter Profile Photo

My Research Webinar from last night now available on the BOPA website - you must be logged in as at least a FREE member to access this resource! Thank you julianlindsay_ @NickDun28458375 COSA CPG COSA bopa.org.uk/lessons/webina…

Muge Cevik (@mugecevik) 's Twitter Profile Photo

No one seems to be interested in the actual RCT data on long-term protection of Pfizer in 6 countries at 152 sites. Among 45k participants, while there was a gradual decline, high efficacy against Covid-19 & severe disease was preserved for at least 6m. nejm.org/doi/full/10.10…

No one seems to be interested in the actual RCT data on long-term protection of Pfizer in 6 countries at 152 sites. Among 45k participants, while there was a gradual decline, high efficacy against Covid-19 &amp; severe disease was preserved for at least 6m.
nejm.org/doi/full/10.10…
TransplantID Journal (@thetxidjournal) 's Twitter Profile Photo

Dynamics of EBV on PTLD after ATG‐conditioned allo HCT by julianlindsay_ & colleagues NCIC. EBV DNA-emia >10,000 strongly associated with PTLD. Rapid rise in viral load common, so should inform screening & potentially future interventions. #TxID onlinelibrary.wiley.com/doi/10.1111/ti…

NCIC (@ncicancer) 's Twitter Profile Photo

A new alternative primary antifungal prophylaxis after allogeneic HCT, the largest S-ITZ study published to date @ncas Peter Mac Health Services Research Michelle Yong julianlindsay_ academic.oup.com/ofid/article/8…

Ben Teh (@benwteh) 's Twitter Profile Photo

An update to the antifungal guidelines to end the year. Enjoyed working on it with Dan YEOH Gabrielle Haeusler julianlindsay_ monica slavin and more - Hope it proves useful to clinicians! NCIC NCAS_Australia ASIDANZ onlinelibrary.wiley.com/doi/10.1111/im…

Oliver Cornely (@cornelyoliver) 's Twitter Profile Photo

šŸ„‡of 2 worlds: targeted #AML #MyeloidLeukaemia treatment & #IFI prophylaxis. Recommendations for patients: 20 targeted drugs x all antifungal classes The Lancet Haematology thelancet.com/journals/lanha… Jannik Stemler @nadejonge Nicole Skoetz @VPiechotta Ronen Ben-Ami European Hematology Association

šŸ„‡of 2 worlds: targeted #AML #MyeloidLeukaemia treatment &amp; #IFI prophylaxis.  
Recommendations for patients: 20 targeted drugs x all  antifungal classes <a href="/TheLancetHaem/">The Lancet Haematology</a> 
thelancet.com/journals/lanha… 
<a href="/JannikStemler/">Jannik Stemler</a> @nadejonge <a href="/NSkoetz/">Nicole Skoetz</a> @VPiechotta <a href="/RonenBenAmi/">Ronen Ben-Ami</a> <a href="/EHA_Hematology/">European Hematology Association</a>
Michelle Yong (@michyong2) 's Twitter Profile Photo

Well done julianlindsay_ on your research on anti fungal usage showing sub-therapeutic voriconazole levels. More work to be done! Lovely to cstch up with you at #Tandem22 NCIC

Well done <a href="/JulianLindsay_/">julianlindsay_</a> on your research on anti fungal usage showing sub-therapeutic voriconazole levels. More work to be done! Lovely to cstch up with you at #Tandem22 <a href="/NCICancer/">NCIC</a>
julianlindsay_ (@julianlindsay_) 's Twitter Profile Photo

Proud to have represented Fred Hutchinson Cancer Center and NCIC at #Tandem22! Inspired by presentations by friends and colleagues leading the field, from mice models by Simone Minnie, to clinical practice by Joshua Hill, MD, to guidelines by Michelle Yong. It’s the ASTCT full circle!

Proud to have represented <a href="/fredhutch/">Fred Hutchinson Cancer Center</a> and <a href="/NCICancer/">NCIC</a> at #Tandem22! Inspired by presentations by friends and colleagues leading the field, from mice models by <a href="/simone_minnie/">Simone Minnie</a>, to clinical practice by <a href="/JoshuaHillMD/">Joshua Hill, MD</a>, to guidelines by <a href="/michyong2/">Michelle Yong</a>. It’s the <a href="/ASTCT/">ASTCT</a> full circle!
Ricardo M. La Hoz (@ricardolahozmd) 's Twitter Profile Photo

Learned a ton from my co-panelists, monica slavin, Dimitrios Kontoyiannis, julianlindsay_, David Fredricks, discussing Challenging Fungal Cases at the HutchIDSciences 4th Symposium ID in ICH #IDSymp23! Thank you for the opportunity to participate.

Learned a ton from my co-panelists, <a href="/monicaslavin/">monica slavin</a>, Dimitrios Kontoyiannis, <a href="/JulianLindsay_/">julianlindsay_</a>, David Fredricks, discussing Challenging Fungal Cases at the <a href="/HutchIDScience/">HutchIDSciences</a> 4th Symposium ID in ICH #IDSymp23! Thank you for the opportunity to participate.